Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary shares, par value 0.002 GBP per share
-
Shares outstanding
-
147,336,360
-
Total 13F shares
-
86,506,981
-
Share change
-
+3,107,240
-
Total reported value
-
$781,158,600
-
Put/Call ratio
-
25%
-
Price per share
-
$9.03
-
Number of holders
-
79
-
Value change
-
+$28,058,050
-
Number of buys
-
18
-
Number of sells
-
3
Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) as of Q2 2024
As of 30 Jun 2024,
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,506,981 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, GENERAL ATLANTIC, L.P., EcoR1 Capital, LLC, First Light Asset Management, LLC, PERCEPTIVE ADVISORS LLC, Vida Ventures Advisors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., TCG Crossover Management, LLC, and FMR LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.